News & Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Ken & Ruth Davee Department of Neurology.
Insertable cardiac monitors detected a higher incidence of atrial fibrillation in patients with prior ischemic stroke over a three-year period than standard medical monitoring methods, according to results published in JAMA Neurology, based on long-term findings from the Northwestern Medicine-led STROKE AF clinical trial.
A new Northwestern Medicine study has uncovered previously unidentified intracellular mechanisms in the peripheral nervous system that cause Charcot–Marie–Tooth Type 2B disease, findings that may inform the development of new targeted therapies.
A pair of recent studies from the laboratory of Evangelos Kiskinis, PhD, have uncovered novel cellular mechanisms that are involved in two types of genetic ALS, providing support for future development of targeted therapies to treat the disease.
Scientists have uncovered a genetic explanation for a subset of common brain tumors, according to a study published in Nature Communications.
A new Northwestern Medicine study has demonstrated how differences in neural activity within the brain’s olfactory and orbital cortices cause people to perceive the same odors differently, according to findings published in Nature Neuroscience.
A new study suggests that a dysfunction in neurons’ synapses leads to deficits in dopamine and precedes the neurodegeneration previously thought to cause Parkinson’s disease.
An experimental drug targeting a genetic variant linked to Parkinson’s disease had no effect on patients, according to the results of a new clinical trial published in The Lancet Neurology.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a renewed five-year $10.8 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute for the Lurie Cancer Center to advance translational research and improve outcomes for patients with brain cancer.
A new Northwestern University-led study published in Nature Neuroscience has discovered that dopamine neurons are more diverse than previously thought, opening new research directions for further understanding and potentially even treating Parkinson’s disease.
Northwestern Medicine scientists have uncovered a new mechanism by which mutations in a specific gene contribute to familial forms of Parkinson’s disease, which opens an avenue for new therapeutics.
A recent Northwestern Medicine study has revealed that the brain’s temporal pole has critical functions in word comprehension, face recognition and the regulation of behavior.
A team led by Northwestern Medicine investigators have discovered novel cellular mechanisms that lead to chemotherapy resistance in recurrent glioblastoma, according to findings published in Science Advances.
Northwestern Medicine scientists have discovered how octopamine, the major “fight-or-flight” neurotransmitter in invertebrates, communicates with other cells to prevent cell death in mammalian brains, according to a study published in the Proceedings of the National Academy of Sciences.
Repeat radiation therapy combined with monoclonal antibody treatment extended progression-free survival in patients with recurrent glioblastoma, according to a recent clinical trial published in the Journal of Clinical Oncology.
For many neurological diseases, such as Parkinson's disease and amyotrophic lateral sclerosis (ALS), conventional drug development strategies have barely scratched the surface in curing the disease in patients.
Sandra Weintraub, PhD, professor of Psychiatry and Behavioral Sciences in the Division of Psychology and associate director of the Northwestern Alzheimer’s Disease Research Center in the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, was recently appointed to the Illinois Supreme Court Commission on Elder Law.
- 03.28.2023The NextGen NeuroGeneticists (NG2) Summer Undergraduate Research Grant program provides driven undergraduate students with opportunities to perform cutting-edge neurogenetics research at Northwestern University.
Ewa Bomba-Warczak, PhD, is employing metabolic stable isotope pulse-chase labelling and high-resolution shotgun mass spectrometry to track and characterize long-lived mitochondrial proteins in the brain throughout a mouse’s lifespan.
Northwestern Medicine scientists have identified the cause of a genetic subtype of autism and schizophrenia that results in social deficits and seizures in mice and humans.
Northwestern Medicine scientists have discovered two ways to preserve diseased upper motor neurons that would normally be destroyed in ALS.
A new Northwestern Medicine study shows antibodies generated by prior vaccinations or infections can actually “hurt” subsequent COVID-19 booster shots.
Targeting calcium signaling in neurons may represent a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study.
- 02.02.2023On January 1, 2023, Robert Vassar, PhD, assumed the role of Director of the Mesulam Center, after Marsel Mesulam, MD, stepped down from the position following 28 years of leadership.
Northwestern scientists have created the first highly mature neurons from human induced pluripotent stem cells, a feat that opens new opportunities for medical research and potential transplantation therapies for neurodegenerative diseases.
A new Northwestern Medicine study has discovered the role of cerebrospinal fluid in cognitive impairment, such as Alzheimer’s disease.
- 12.05.2022As 2023 peers around the corner, people will no doubt begin thinking through their lists of New Year’s resolutions. While healthy eating, exercise, budgeting and others are important, cardiology and sleep medicine experts at Northwestern Medicine are encouraging one goal to be on everyone’s lists: getting better sleep.